Yasutaka Mochizuka Selected Research

Yasutaka Mochizuka Research Topics

2	Neoplasms (Cancer) 04/2024 - 01/2020
2	Idiopathic Pulmonary Fibrosis 01/2023 - 01/2021
1	Oncogene Addiction 04/2024
1	Disease Progression 02/2024
1	Fibrosis (Cirrhosis) 05/2023
1	Hemorrhage 05/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Malnutrition (Nutritional Deficiencies) 01/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Dyspnea (Shortness of Breath) 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Bronchiolitis Obliterans Syndrome 01/2023
1	Eosinophilia 01/2022
1	COVID-19 01/2022
1	Leukopenia 01/2022
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2022
1	Cryptogenic Organizing Pneumonia 01/2022
1	Infections 10/2021
1	Nontuberculous Mycobacterium Infections 10/2021
1	Hypersensitivity (Allergy) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Idiopathic Interstitial Pneumonias 01/2021
1	Thrombosis (Thrombus) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Lymphangitis 01/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020

1	trametinibIBA 04/2024
1	dabrafenibIBA 04/2024
1	AntibodiesIBA 02/2024
1	HemosiderinIBA 05/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	pembrolizumabIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	remdesivirIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	baricitinibIBA 01/2022
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 10/2021
1	AutoantibodiesIBA 10/2021
1	CollagenIBA 01/2021

2	Therapeutics 01/2023 - 01/2022
1	Drug Therapy (Chemotherapy) 01/2020